KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Return on Sales (2016 - 2025)

Historic Return on Sales for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to 0.3%.

  • Gsk's Return on Sales rose 800.0% to 0.3% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.3%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.36% for FY2022, which is 3000.0% up from last year.
  • According to the latest figures from Q4 2025, Gsk's Return on Sales is 0.3%, which was up 800.0% from 0.32% recorded in Q3 2025.
  • Gsk's 5-year Return on Sales high stood at 1.29% for Q3 2022, and its period low was 0.01% during Q3 2024.
  • Its 5-year average for Return on Sales is 0.24%, with a median of 0.22% in 2024.
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 12200bps in 2022, then tumbled by -10400bps in 2023.
  • Quarter analysis of 5 years shows Gsk's Return on Sales stood at 0.02% in 2021, then surged by 114bps to 0.04% in 2022, then skyrocketed by 643bps to 0.33% in 2023, then plummeted by -33bps to 0.22% in 2024, then soared by 38bps to 0.3% in 2025.
  • Its Return on Sales was 0.3% in Q4 2025, compared to 0.32% in Q3 2025 and 0.27% in Q2 2025.